Randomized trial of ingestion method of oral immunotherapy for severe food allergic patients
Not Applicable
Recruiting
- Conditions
- Food allergy
- Registration Number
- JPRN-UMIN000033345
- Lead Sponsor
- ational Hospital Organization Sagamihara National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
Decision of ineligibility by a physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained unresponsiveness to middle-dose after 12 months. Middle dose was defined as "half of a whole egg, 25 ml of cow's milk, 25g of Udon, 3g of peanut or 3g of nut".
- Secondary Outcome Measures
Name Time Method Changes of specific IgE, IgG, IgG4 Frequency of adverse reactions The rate of sustained unresponsiveness to middle-dose after 5 years from start of OIT.